首页> 外国专利> Janus Kinase Inhibitors for the treatment of Dry Eye and other diseases related to the eyes. Ophthalmic Insert

Janus Kinase Inhibitors for the treatment of Dry Eye and other diseases related to the eyes. Ophthalmic Insert

机译:Janus激酶抑制剂,用于治疗干眼症和与眼睛有关的其他疾病。眼科插入物

摘要

Claim 1: a method for the treatment of Dry Eye disorders in a patient in need thereof, characterized in that it comprises administering to the patient a therapeutically effective amount of an agent selected from (a) compounds of formula (1), where A1 and A2 are selec Clients independently between C and N; T, u, and V are selected irrespective of o, S, N, CR5,And NR6; where the five Member Ring formed by A1, A2, and T, u, V is Aromatic; X is n or CR4; and is alquileno C1 C2 alquenileno - 8 - 8 - 8 alquinileno C2 (cr11r12) P - (cicloalquilen C3 - (10) - cr11r12) Q (cr11r12) P - (arilen) - (cr11r12) Q (cr11r12) - (heterocicloalquilen C1 - (10) - cr11r12) Q (P - (heteroa cr11r12) Rilen) - (cr11r12) Q (cr11r12) PO (cr11r12) (cr11r12 (Q, q) cr11r12 (PS), cr11r12 (PC) or (Q,) cr11r12)(cr11r12) PC (or NRC) (cr11r12) Q (cr11r12 (PC) or (q) or cr11r12 (OC), cr11r12) (o) (cr11r12) (cr11r12 POC (q) or (q) cr11r12 (NRC), cr11r12 (PNRC) cr11r12) Q (cr11r12) pnrcc (o) (cr11r12 (NRD) cr11r12 PS (q) or (q) cr11r12 (PS), cr11r12 (NRC) or (q) cr11r12 (PS), cr11r12) (OR) 2 (cr11r12) or (Q, cr11r12 (PS) or (q) 2nrc cr11r12), where said alkyd Full alquenileno C2 C1 - 8 - 8 - 8 alquinileno C2, cicloalquileno, arylene, heterocicloalquileno,Heteroarileno is replaced or, optionally with 1, 2, or 3 substituents selected independently between D1 D2 D3 D4; Z is H, alkyl, Halo, C1 C2 alquenilo - 8 - 8 - 8 haloalquilo alquinilo C2, C1 - 4, halosulfanilo, hidroxialquilo c1-4, cianoalquilo c1-4, - n = c = RI, RI, Cy1, CN, NO2, ora, Mrs. C (or RB), C (o) C (o) nrcrd, ora, OC (or RB), OC (OR) nrcrd, nrcrd, NRCC (or RB), (OR) nrcrd NRCC, NRCC (or Lady)C = (NRI) nrcrd, NRCC (= nrcrd NRI), S (or RB), S (or S) nrcrd 2rb, (OR), (OR) NRCS 2rb, C (= Noh) (RB, c = (C1 - (6) and (OR) RB, S 2nrcrd, where The alkyl alquenilo C2 C1 - 8 - 8 - 8, or alquinilo C2 is replaced with either 1, 2, 3, 4, 5, or 6 selected regardless of Halo substituents, c1-4 alkyl Alquenilo C2, C2 - 4 - 4, alquinilo, haloalquilo c1-4, halosulfanilo, hidroxialquilo c1-4,Cianoalquilo c1-4, CY1, CN, NO2, ora, MS, RB, C (o) C (o) C (o) nrcrd, ora, OC (or RB), OC (OR) nrcrd, nrcrd, NRCC (or RB), (OR) nrcrd NRCC, NRCC (ORA) c = (NRI) nrcrd, NRCC (= nrcrd NRI), S (or RB), S (or S) nrcrd 2rb, (OR), (OR) NRCS 2rb, C (= Noh) (RB, c = (C1 - RB (6)), and S (OR) 2nrcrd; where z is h, N is 1 - (or portion; N - Z) and A2 (i) taken together with the portion to which is United, (ii) R5 or R6 of both T and VAnd (iii) The c or n Atom to which the R5 or R6 of both T and V are United to form a ring, cycloalkyl, aryl, heteroaryl, or 4 to 20 members heterocicloalquilo Ring FUSED to the 5 Member formed by A1, A2, and T, u, V, where the aryl ring, cycloalkyl, heteroaryl or h Eterocicloalquilo 4 to 20 members are optionally replaced with 1, 2, 3, 45 substituents or independently selected from - (W) M - Q; W is alquilenilo C1 C2 alquenilenilo - 8 - 8 - 8 alquinilenilo C2, o, S, C (o) C (or NRC), C (o) or oC (OC), (or NRC) 'NRC NRC', 'C' (NRD), S (or S), (OR) NRC 's (OR) 2, and (OR) 2nrc' s; Q is H, alkyl, Halo, CN, NO2, C1 C2 alquenilo - 8 - 8 - 8 alquinilo C2 Haloalquilo C1, - 8, halosulfanilo, cycloalkyl, aryl, heteroaryl or heterocicloalquilo,Where the alkyl alquenilo C2 C1 - 8 - 8 - 8 haloalquilo alquinilo C2, C1 - 8, cycloalkyl, aryl, heteroaryl or heterocicloalquilo optionally replaced with 1, 2, 3 or 4 substituents selected independently between c1-4 alkyl, Halo, alquenilo C2 - 4, alquinilo haloalquilo C1 C2 - 4 - 4, h Alosulfanilo, hidroxialquilo c1-4, cianoalquilo c1-4, Cy2, CN, NO2, or ',' c '(or RB),C (or c) NRC 'rd', or '(OR), OC (OC (or RB)', or 'rd') NRC NRC NRC 'rd', 'c' (or RB), NRC (NRC) 'c' rd ',' C (or NRC) ora 's (or RB), S (or NRC)' rd 's (or NRC) 2rb' (or 's' s) 2rb and (OR) 2nrc' rd '; CY1 and Cy2 are selected independently between aryl, heteroaryl, and heterocicloalquilo cycloalkyl, optionally substituted, each With 1, 2, 3, 4 or 5 substituents selected independently between c1-4 alkyl, haloAlquenilo alquinilo C2 C2 - 4 - 4, haloalquilo c1-4, halosulfanilo, hidroxialquilo c1-4, cianoalquilo c1-4, NO2 or CN, '', '', C '' (or RB), C (or NRC) 'rd', 'c' (OR) ora 'rb' (or OC), OC (or NRC) 'rd', NRC NRC 'rd' ',' 'c' '(or RB), NRC (NRC)' 'c' 'rd', 'c' (or NRC) Pray, '' s (or RB) ',' s' (or NRC) 'rd', 's' (OR) 2rb, NRC' s (OR) 2 Rb, and S (OR) 2nrc 'rd', R1, R2, R3 and R4 are selected independently from h, haloC1-4 alkyl, alquenilo alquinilo C2 C2 - 4 - 4, haloalquilo c1-4, halosulfanilo, cycloalkyl, aryl, heteroaryl, heterocicloalquilo, CN, NO2, or7, SR7, R8, C (o) C (o) C (o) nr9r10, or7, OC (OC (R8), nr9r10 nr9r10 or), (OR), nr9c R8, nr9c (or or7), S (R8), S (or S) nr9r10, (OR) 2r8, nr9s 2r8 (OR), and S (OR) is 2nr9r10; R5 h, h Hello, c1-4 alkyl, alquenilo alquinilo C2 C2 - 4 - 4, haloalquilo c1-4, halosulfanilo, CN, NO2, or7,SR7, R8, C (o) C (o) C (o) or7 nr9r10, R8, OC (OC), (OR) nr9r10, nr9r10, nr9c (or nr9c (R8), or or7), S (R8), S (or S) nr9r10 2r8 (,, OR) nr9s 2r8 (OR), or s (OR) 2nr9r10; R6 is H, alkyl alquenilo C1 - C2 - 4, 4, 4 alquinilo haloalquilo C1 - C2, 4, or7, R8, C (o) C (o) C (o) nr9r10, or7, R8, S (or S) nr9r10 (or), (OR) 2r8 s, or s (OR) is 2nr9r10; R7 H, alkyl haloalquilo C1 C1 - 6, - 6, - 6 alquinilo alquenilo C2, C2 - 6, cycloalkyl, aryl,Heteroaryl, heterocicloalquilo, arylalkyl or heterocicloalquilalquilo, heteroarilalquilo, cicloalquilalquilo; R8 is H, alkyl haloalquilo C1 C1 - 6, - 6, - 6 alquinilo alquenilo C2, C2 - 6, cycloalkyl, aryl, heteroaryl, heterocicloalquilo, arylalkyl or cicloalquilalquilo, heteroarilalquilo, Heterocyclic Icloalquilalquilo; R9 and R10 is independently selected from h, alkyl C1 - 10Haloalquilo C1 - C2 - alquenilo 6, 6, 6 alquinilo alquilcarbonilo C1 C2, C1 alquilsulfonilo arilcarbonilo, - 6, - 6, arilsulfonilo, cycloalkyl, aryl, heteroaryl, heterocicloalquilo, arylalkyl, heteroarilalquilo, cicloalquilalquilo and heterocicloalquilalquilo; R9 and R10 or together with the atom of the cua L are connected to form a Group heterocicloalquilo 4, 56 or 7 members; R11 and R12 are independently selected from H and - E1 - E2 E3 E4; D1 and E1 are absent or are selected independently, regardless of alquileno C1 - C2 - alquenileno 6, 6, 6 alquinileno C2, arylene, cicloalquileno, heteroarileno, and heterocicloalquileno, where C Each of alquileno C1 - C2 - alquenileno 6, 6, 6 alquinileno C2, arylene, cicloalquileno,Heteroarileno, and optionally heterocicloalquileno is replaced with 1, 2 or 3 substituents selected independently between Halo, CN, NO2, N3, SNA, Oh, alkyl - 6 haloalquilo C1, C1 - C2 alkoxyalkyl Esters 6, - 8, - 6 haloalcoxi alkoxy C1, C1 - 6, 6 - amino alquilamino C1, C2, and dialquilamino - 8; D2 and E2 Regardless are absent or are selected independently between alquileno C1 - 6Alquenileno C2 - 6, 6 - (rent alquinileno C2, C1 - (6) - R or - C1 - 6 Rent (rent) s, C1 - R - S - (6) Let C1 - 6) s, (C1 - 6 - Rent (rent) R NRE - C1 - 6) s r (rent C1 - 6) - CO - (C1 - 6 Rent (rent) s, C1 - 6) R - C (o) o - (C1 - Rent (rent C1 s, 6) - 6 - (R) - conre C1 - 6 Rent (rent) s, C1 - 6) R - os - (rent C1 - 6 S (R), rent (rent) - SO2 - C1 - 6 (S,) Let C1 - 6 - (R) - you get s, C1 - 6)(rent) - and R - (- nreconrf Rent C1 6) s, where each of alquileno - 6 alquenileno C1, C2 and C2 - 6, 6 - alquinileno optionally replaced with 1, 2 or 3 substituents selected independently between Halo, CN, NO2, N3, SNA, Oh, alkyl C1 - 6 haloalquilo C1, C2 alkoxyalkyl esters - 6, - 8, - alkoxy C1 6 Haloalcoxi C1 - 6, amino, alquilamino C1 - 6And dialquilamino C2 - 8; D3 and E3 are absent or are selected independently, regardless of alquileno C1 - C2 - alquenileno 6, 6, 6 alquinileno C2, arylene, cicloalquileno, heteroarileno, and heterocicloalquileno, where each of alquileno C1 - C2 - alquenileno 6, 6, 6 alquinileno C2, Cicloalquileno, arylene, heteroarileno, and optionally heterocicloalquileno is replaced with 12 or 3 substituents selected regardless of its Halo, CN, NO2, N3, SNA, Oh, alkyl haloalquilo C1 C1 - 6 - 6, 6 - alkoxy alkoxyalkyl Esters C1, C1 haloalcoxi - 6, 6 - amino alquilamino C1, C1, and C2 - 6, - 8 dialquilamino D4 and E4 are selected independently; between h, c1-4 alkyl, Halo, alquenil Alquinilo C2 or C2 - 4, - 3, - 4 halosulfanilo haloalquilo C1, C1, C1 cianoalquilo hidroxialquilo - 4 - 4Cy1, CN, NO2, ora, MS, RB, C (o) C (o) C (o) nrcrd, ora, OC (or RB), OC (OR) nrcrd, nrcrd, NRCC (or Rb (NRCC), or nrcrd (NRCC), C (= o) ora, NRI nrcrd, NRCC (NRI) = S (o)) nrcrd, RB, S (or S) nrcrd 2rb, (OR), (OR) NRCS 2rb, C (= Noh) (RB, c = (C1 - (6) and S (RB), or where the alkyl 2nrcrd); alquenilo C1 C1 - 8, - 8, - 6 or alquinilo C1, Optionally replaced with 1, 2, 3, 4, 5,Or 6 substituents selected independently between c1-4 alkyl, Halo, alquenilo alquinilo C2 C2 - 4 - 4, haloalquilo c1-4, halosulfanilo, hidroxialquilo c1-4, cianoalquilo c1-4, CY1, CN, NO2, ora, MS, RB, C (o) C (o) C (nrcrd, ora, OC (OR) or oC (RB), or nrcrd nrcrd, NRCC), Rb (OR), (OR) nrcrd NRCC, NRCC (or Lady) C = (NRI) nrcrd, NRCC (= nrcrd NRI), S (or RB), S (or S) nrcrd 2rb, (OR), (OR) NRCS 2rb, RB, C (= Noh)C = (C1 - 6 (RB)), and S (OR) 2nrcrd; RA - (CY1 is H, alkyl, C1 - 6) - alkyl - 6 CY1, C1, C2 alquenilo haloalquilo C1 - 6, - 6, - 6 alquinilo C2, where the alkyl haloalquilo C1 - 6 6 alquenilo C1, C2 or C2 - 6, 6 - alquinilo optionally replaced with 1, 2, or 3 substituents selected independently Between Oh, CN, amino alkyl, Halo, haloalquilo C1 C1 - 6 - 6, halosulfanilo, aryl, arylalkyl,Heteroaryl, heteroarilalquilo, cycloalkyl and heterocicloalquilo; Rb (CY1 is H, alkyl, - C1 - 6) - alkyl - 6 CY1, C1, C2 alquenilo haloalquilo C1 - 6, - 6, - 6 alquinilo C2, where the alkyl haloalquilo C1 C1 - 6, - 6, - 6 alquenilo C2 or C2 alquinilo 6 be replaced optionally with 1, 2, or 3 substituents are Selected independently between Oh, CN, amino alkyl, alkyl, Halo, Halo, C1 - 6Haloalquilo C1 - 6, halosulfanilo, aryl, heteroaryl, arylalkyl, heteroarilalquilo, cycloalkyl and heterocicloalquilo; ra and Ra 'are selected independently from h, alkyl haloalquilo C1 C1 - 6, - 6, - 6 alquinilo alquenilo C2, C2 - 6, cycloalkyl, aryl, heteroaryl, heterocicloalquilo, arilalq Uilo, heteroarilalquilo, cicloalquilalquilo and heterocicloalquilalquilo
机译:1。一种在有此需要的患者中治疗干眼症的方法,其特征在于,该方法包括向该患者给药治疗有效量的选自(a)式(1)化合物的药物,其中A1和A2是C和N之间的独立客户;无论o,S,N,CR5和NR6如何选择T,u和V;其中由A1,A2和T,u,V形成的五个成员环是芳族的; X为n或CR4;并且是alquileno C1 C2 alquenileno-8-8-8 alquinileno C2(cr11r12)P-(cicloalquilen C3-(10)-cr11r12)Q(cr11r12)P-(arilen)-(cr11r12)Q(cr11r12)-(heterociclocloalquilen C1 -(10)-cr11r12)Q(P-(heteroa cr11r12)Rilen)-(cr11r12)Q(cr11r12)PO(cr11r12)(cr11r12(Q,q)cr11r12(PS),cr11r12(PC)或(Q,) cr11r12)(cr11r12)PC(或NRC)(cr11r12)Q(cr11r12(PC)或(q)或cr11r12(OC),cr11r12)(o)(cr11r12)(cr11r12 POC(q)或(q)cr11r12(NRC) ),cr11r12(PNRC)cr11r12)Q(cr11r12)pnrcc(o)(cr11r12(NRD)cr11r12 PS(q)或(q)cr11r12(PS),cr11r12(NRC)或(q)cr11r12(PS),cr11r12) (OR)2(cr11r12)或(Q,cr11r12(PS)或(q)2nrc cr11r12),其中所说的醇酸全alquenileno C2 C1-8-8-8 alquinileno C2,cicloalquileno,亚芳基,heterocicloalquileno,Heteroarileno被取代或任选地具有1、2或3个在D1D2,D3,D4之间独立选择的取代基; Z是H,烷基,卤素,C1 C2 alquenilo-8-8-8 haloalquilo alquinilo C2,C1-4,halosulfanilo,hidroxialquilo c1-4,cianoalquilo c1-4,-n = c = RI,RI,Cy1,CN NO2,ora,C女士(或RB),C(o)C(o)nrcrd,ora,OC(或RB),OC(OR)nrcrd,nrcrd,NRCC(或RB),(OR)nrcrd NRCC, NRCC(或Lady)C =(NRI)nrcrd,NRCC(= nrcrd NRI),S(或RB),S(或S)nrcrd 2rb,(OR),(OR)NRCS 2rb,C(= Noh)(RB ,c =(C1-(6)和(OR)RB,S 2nrcrd,其中烷基alquenilo C2 C1-8-8-8或alquinilo C2被1、2、3、4、5或6取代不论卤素取代基,c1-4烷基Alquenilo C2,C2-4-4,alquinilo,卤代alquiloc1-4,hallosulfanilo,hidroxialquilo c1-4,Cianoalquilo c1-4,CY1,CN,NO2,ora,MS,RB, C(o)C(o)C(o)nrcrd,ora,OC(或RB),OC(OR)nrcrd,nrcrd,NRCC(或RB),(OR)nrcrd NRCC,NRCC(ORA)c =(NRI )nrcrd,NRCC(= nrcrd NRI),S(或RB),S(或S)nrcrd 2rb,(OR),(OR)NRCS 2rb,C(= Noh)(RB,c =(C1-RB(6 ))和S(OR)2nrcrd;其中z为h,N为1- (或部分; N-Z)和A2(i)以及与之相连的部分(ii)T和V的R5或R6和(iii)T和V的R5或R6分别为c或n Atom结合形成一个环,环烷基,芳基,杂芳基或4至20个成员的杂环基杂环基FUSED至由A1,A2和T,u,V形成的5个成员,其中芳基环,环烷基,杂芳基或h 20个成员任选地被1、2、3、45个取代基取代,或独立地选自-(W)M-Q; W是alquilenilo C1 C2 alquenilenilo-8-8-8 alquinilenilo C2,o,S,C(o)C(或NRC),C(o)或oC(OC),(或NRC)'NRC NRC','C (NRD),S(或S),(OR)NRC(OR)2和(OR)2nrc'; Q是H,烷基,卤代,CN,NO2,C1 C2烷基-8-8-8烷基C2卤代alquilo C1,-8,卤代磺胺基,环烷基,芳基,杂芳基或杂环烷基,其中烷基alquenilo C2 C1-8-8- 8个卤代alquilolo C2,C1-8,环烷基,芳基,杂芳基或杂环烷氧基可任选被1、2、3或4个取代基取代,所述取代基独立地选自c1-4烷基,卤代,alquenilo C2-4,alquinilo卤代alquilo C1 C2-4-4 ,h Alosulfanilo,hidroxialquilo c1-4,cianoalquilo c1-4,Cy2,CN,NO2或','c'(或RB),C(或c)NRC'rd',或'(OR),OC(OC (或RB)'或'rd')NRC NRC NRC'rd','c'(或RB),NRC(NRC)'c'rd','C(或NRC)ora的(或RB), S(或NRC)'rd's(或NRC)2rb'(或's')2rb和(OR)2nrc'rd'; CY1和Cy2独立地选自任选被取代的芳基,杂芳基和杂环芳基环烷基,各自具有1、2、3、4或5个独立地选自c1-4烷基,卤代Alquenilo alquinilo C2 C2-4 -4,4卤代芳基c1-的取代基。 4,halosulfanilo,hidroxialquilo c1-4,cianoalquilo c1-4,NO2 or CN,'','',C''(或RB),C(或NRC)'rd','c'(OR)ora'rb '(或OC),OC(或NRC)'rd',NRC NRC'rd'','c''(或RB),NRC(NRC)''c''rd','c'(或NRC )祈祷,``s(或RB)','s'(或NRC)'rd','s'(OR)2rb,NRC's(OR)2 Rb和S(OR)2nrc'rd', R1,R2,R3和R4分别选自h,卤代C1-4烷基,alquenilo alquinilo C2-42-4,卤代alquilo c1-4,卤代磺酰苯胺,环烷基,芳基,杂芳基,杂环氯基,CN,NO2或or7,SR7, R8,C(o)C(o)C(o)nr9r10,or7,OC(OC(R8),nr9r10 nr9r10 or),(OR),nr9c R8,nr9c(or or7),S(R8),S(或S)nr9r10,(OR)2r8,nr9s 2r8(OR),且S(OR)为2nr9r10 R5 h,h你好,c1-4烷基,alquenilo alquinilo C2-4-4,卤代alquilo c1-4,卤代磺胺基,CN,NO2,or7,SR7,R8,C(o)C(o)C(o)or7 nr9r10,R8,OC(OC),(OR)nr9r10,nr9r10,nr9c(或nr9c(R8)或or7),S(R8),S(或S)nr9r10 2r8(,或)nr9s 2r8(OR)或s(OR)2nr9r10; R6是H,烷基Alquenilo C1-C2-4,4,4 Alquinilo haloalquilo C1-C2,4,or7,R8,C(o)C(o)C(o)nr9r10,or7,R8,S(或S) nr9r10(或),(OR)2r8 s或s(OR)为2nr9r10; R7 H,烷基卤代烷基C1 C1-6,6-6,6烷基喹啉C2,C2-6,环烷基,芳基,杂芳基,杂环氯基,芳基烷基或杂环芳基喹啉基,杂芳基芳基基团,环戊基芳基基团; R8为H,烷基卤代烷基C1 C1-6、6-6-6 Alquinilo alquenilo C2,C2-6,环烷基,芳基,杂芳基,杂环氯喹啉基,芳基烷基或环氯代喹啉基; R9和R10独立地选自h,烷基C1-10卤代喹啉C1-C2-烷氧基6、6、6烷喹基Alquilcarbonilo C1 C2,C1烷磺酰基alilcarbonilo-6,-6,芳砜基,环烷基,芳基,杂芳基,杂环氯基,芳基烷基,杂芳基喹啉基,异环芳基喹啉基和异环芳基喹啉基; R9和R10或与cua L的原子连接形成异环基喹啉基4、56或7个成员; R11和R12独立地选自H和-E1-E2E3E4;不论alquileno C1-C2-alquenileno 6、6、6 alquinileno C2,亚芳基,cicloalquileno,heterariileno和heterocicloalquileno(其中C分别是Alquileno C1-C2-alquenileno 6,6,6的D1和E1不存在或独立选择) Alquinileno C2,亚芳基,环芳基,杂芳基和任选的杂环芳基被分别在Halo,CN,NO2,N3,SNA,哦,烷基,-6卤代烷基C1,C1-C2烷氧基烷基酯6,-中独立选择的1、2或3个取代基取代8-6卤代烷氧基烷氧基C1,C1-6、6-氨基alquilamino C1,C2和diaquilamino-8; D2和E2无论如何都不存在或在alquileno C1-6Alquenileno C2-6、6-(rent alquinileno C2,C1-(6)-R或-C1-6 Rent(rent)s,C1-R-S- (6)设C1-6)s,(C1-6-租金(租金)R NRE-C1-6)sr(租金C1-6)-CO-(C1-6租金(租金)s,C1-6) R-C(o)o-(C1-租金(租金C1 s,6)-6-(R)-租金C1-6租金(租金)s,C1-6)R-os-(租金C1-6 S (R),租金(租金)-SO2-C1-6(S,)令C1-6-(R)-您得到s,C1-6)(租金)-和R-(-nreconrf租金C1 6)s ,其中每一个alquileno-6 alquenileno C1,C2和C2-6、6-alquinileno都可选地被分别选自Halo,CN,NO2,N3,SNA,Oh,烷基C1-6卤代喹啉C1中的1、2或3个取代基取代, C2烷氧基烷基酯-6,-8,-烷氧基C1 6卤代醇C1-6,氨基,烷氨基C1-6和二烷氨基C2-8;不论alquileno C1-C2-alquenileno 6、6、6 alquinileno C2,亚芳基,cicloalquileno,heterarileno和heterocicloalquileno,D3和E3都不存在或独立选择,其中alquileno C1-C2-alquenileno 6,6,6 alquinileno C 2,Cicloalquileno,亚芳基,杂芳基和任选的杂Cicloalquileno被选择的12个或3个取代基取代,无论其卤素,CN,NO2,N3,SNA,哦,烷基卤代烷基C1 C1-6、6-6、6-烷氧基烷氧基烷基酯C1,独立地选择C 1卤代alcoxi-6、6-氨基alquilamino C1,C1和C2-6-8 dialquilamino D4和E4;在h,c1-4烷基,Halo,alquenil Alquinilo C2或C2-4,-3,-4 halosulfanilo haloalquilo C1,C1,C1 cianoalquilo hidroxialquilolo-4-4Cy1,CN,NO2,ora,MS,RB,C( )C(o)C(o)nrcrd,ora,OC(或RB),OC(OR)nrcrd,nrcrd,NRCC(或Rb(NRCC)或nrcrd(NRCC),C(= o)ora,NRI nrcrd ,NRCC(NRI)= S(o))nrcrd,RB,S(或S)nrcrd 2rb,(OR),(OR)NRCS 2rb,C(= Noh)(RB,c =(C1-(6)和S(RB),或其中的烷基为2nrcrd); alquenilo C1-8,-8,-6或alquinilo C1,可选地被1,2-4、3、4、5或6个在c1-4烷基之间独立选择的取代基取代,Halo,alquenilo alquinilo C2 2-4,halalalquilo c1-4,halosulfanilo,hidroxialquilo c1-4,cianoalquilo c1-4,CY1,CN,NO2,ora,MS,RB,C(o)C(o)C (nrcrd,ora,OC(OR)或oC(RB)或nrcrd nrcrd,NRCC),Rb(OR),(OR)nrcrd NRCC,NRCC(或Lady)C =(NRI)nrcrd,NRCC(= nrcrd NRI ),S(或RB),S(或S)nrcrd 2rb,(OR),(OR)NRCS 2rb,RB,C(= Noh)C =(C1-6(RB))和S(OR)2nrcrd ; RA-(CY1是H,烷基,C1 -6)-烷基-6 CY1,C1,C2 alquenilo haloalquilo C1-6,-6,-6 alquinilo C2,其中烷基卤代alquilolo C1-6 6 alquenilo C1,C2或C2-6,6-alquinilo可选地被1取代,2或3个独立的取代基,其选自Oh,CN,氨基烷基,卤代,卤代alquilo 1 1-6-6,卤代磺胺基,芳基,芳基烷基,杂芳基,杂芳基,环烷基和杂环基。 Rb(CY1为H,烷基--C1-6)-烷基-6 CY1,C1,C2烷基卤代alquiilo C1-6-6-6烷基喹啉C2,其中烷基卤代alquilolo C1 C1-6--6-6 Alquenilo C2或C2 alquinilo 6可选地被1、2或3个取代基取代在OH,CN,氨基烷基,烷基,Halo,Halo,C1-6卤代烷基C1-6,卤代磺胺基,芳基,杂芳基,芳基烷基,杂芳基环戊基之间独立选择,环烷基和杂环烷基; ra和Ra'独立地选自h,烷基卤代alquilo C1-6--6-6-alquinilo alquenilo C2,C2-6,环烷基,芳基,杂芳基,杂环氯基,alilalq Uilo,杂芳基环基,cicloalquilalquilo和杂环基

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号